the market?
Dynavax Technologies Corp
NASDAQ: DVAX
1.13
0.09
(8.65%)
| Today's Open | $1.04 |
|---|---|
| Previous Close | $1.04 |
| Daily Range | $1.02 - $1.14 |
| 52-Week Range | $0.99 - $5.10 |
| Market Cap | $206.7M |
| P/E Ratio | -2.54 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 6,738,204 |
| Average Daily Volume | 3,490,922 |
| Current FY EPS | -$0.40 |
How do you think DVAX
will perform against the market?
Top DVAX Bull/Bear Pitches
foolphighter (0)
Submitted
January 12, 2007
Small biotech has recently released promising late stage trial results for its HEPLSAV hepatitus B vaccine drug, as well as encouraging earlier stage results for its TLR9 agonist in cancer indications … More
News & Commentary
SHAREHOLDER ALERT: Brower Piven Announces an Investigation of Dynavax Technologies Corporation for P
3 Horrendous Health-Care Stocks This Week
Had a bad week? Seeing how horribly these stocks performed might make you feel better by comparison.Why Dynavax Technologies Shares Were Eviscerated
Things go from bad to worse when the Food and Drug Administration sends Dynavax packing.Hot Off the Press: Dynavax Tumbles 30%
What caused this biotech to crash this morning?Here's What This $5 Billion Hedge Fund Has Been Buying
It can pay off to keep an eye on the big guys.Sector
Healthcare
Industry
Drugs
Dynavax Technologies Corp (DVAX) Description
A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory. Website: http://www.dynavax.com/
More details for Dynavax Technologies Jobs
Dynavax Technologies reviews from employees
